Crossmark

SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 1: Epidemiology, risk factors and prognosis

Crossref DOI link: https://doi.org/10.1016/j.reumae.2022.02.004

Published Print: 2022-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Rodríguez Portal, José Antonio

Brito García, Noé

Díaz del Campo Fontecha, Petra

Valenzuela, Claudia

Ortiz, Ana María

Nieto, M. Asunción

Mena-Vázquez, Natalia

Cano-Jiménez, Esteban

Castellví, Iván

Aburto, Myriam

Bonilla, Gema

Hernández Hernández, María Vanesa

Francisco Hernández, Félix Manuel

Correyero Plaza, María

Castrejón, Isabel

Abad Hernández, Miguel Ángel

Narváez, Javier
License Information

Text and Data Mining valid from 2022-10-01
More Information

This article is maintained by: Elsevier

Article Title: SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 1: Epidemiology, risk factors and prognosis

Journal Title: Reumatología Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reumae.2022.02.004

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.reuma.2022.02.009

Content Type: article

Copyright: © 2022 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.

Document is current

Any future updates will be listed below